{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T07:59:14Z","timestamp":1777881554141,"version":"3.51.4"},"publisher-location":"Cham","reference-count":73,"publisher":"Springer Nature Switzerland","isbn-type":[{"value":"9783032231710","type":"print"},{"value":"9783032231727","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-3-032-23172-7_4","type":"book-chapter","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:46:13Z","timestamp":1777596373000},"page":"59-79","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Computational Approaches and Structure-Based Drug Design of CAIs"],"prefix":"10.1007","author":[{"given":"Alessandro","family":"Bonardi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Gratteri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,5,1]]},"reference":[{"key":"4_CR1","doi-asserted-by":"publisher","DOI":"10.1080\/14756366.2024.2335927","volume":"39","author":"M Abdoli","year":"2024","unstructured":"Abdoli M, Bonardi A, Gratteri P, Supuran CT, \u017dalubovskis R (2024) Synthesis, carbonic anhydrase inhibition studies and modelling investigations of phthalimide-hydantoin hybrids. J Enzyme Inhib Med Chem 39:2335927. https:\/\/doi.org\/10.1080\/14756366.2024.2335927","journal-title":"J Enzyme Inhib Med Chem"},{"key":"4_CR2","doi-asserted-by":"publisher","first-page":"10","DOI":"10.2174\/157340911793743547","volume":"7","author":"C Acharya","year":"2011","unstructured":"Acharya C, Coop A, Polli JE, Mackerell AD Jr (2011) Recent advances in ligand-based drug design: relevance and utility of the conformationally sampled pharmacophore approach. Curr Comput Aided Drug Des 7:10\u201322. https:\/\/doi.org\/10.2174\/157340911793743547","journal-title":"Curr Comput Aided Drug Des"},{"key":"4_CR3","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.3390\/cimb44030068","volume":"44","author":"A Ali","year":"2022","unstructured":"Ali A, Ali A, Warsi MH, Rahman MA, Ahsan MJ, Azam F (2022) An insight into the structural requirements and pharmacophore identification of carbonic anhydrase inhibitors to combat oxidative stress at high altitudes: an in-silico approach. Curr Issues Mol Biol 44:1027\u20131045. https:\/\/doi.org\/10.3390\/cimb44030068","journal-title":"Curr Issues Mol Biol"},{"key":"4_CR4","doi-asserted-by":"publisher","first-page":"16233","DOI":"10.1073\/pnas.0908301106","volume":"106","author":"V Alterio","year":"2009","unstructured":"Alterio V, Hilvo M, Di Fiore A et al (2009) Crystal structure of the catalytic domain of the tumor-associated human carbonic anhydrase IX. Proc Natl Acad Sci USA 106:16233\u201316238. https:\/\/doi.org\/10.1073\/pnas.0908301106","journal-title":"Proc Natl Acad Sci USA"},{"key":"4_CR5","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1002\/cre2.723","volume":"9","author":"R Al-Mahdi","year":"2023","unstructured":"Al-Mahdi R, Al-Sharani H, Al-Haroni M, Halboub E (2023) Associations of the activity and concentration of carbonic anhydrase VI with susceptibility to dental caries: a systematic review and meta-analysis. Clin Exp Dent Res 9:358\u2013367. https:\/\/doi.org\/10.1002\/cre2.723","journal-title":"Clin Exp Dent Res"},{"key":"4_CR6","doi-asserted-by":"publisher","DOI":"10.2174\/0115701638361318241230073123","volume":"22","author":"U Agarwal","year":"2025","unstructured":"Agarwal U, Tonk RK, Paliwal S (2025) Importance of computer-aided drug design in modern pharmaceutical research. Curr Drug Discov Technol 22:e15701638361318. https:\/\/doi.org\/10.2174\/0115701638361318241230073123","journal-title":"Curr Drug Discov Technol"},{"key":"4_CR7","doi-asserted-by":"publisher","first-page":"4234","DOI":"10.3390\/cimb46050258","volume":"46","author":"R Antonelli","year":"2024","unstructured":"Antonelli R, Massei V, Ferrari E, Gallo M, Pertinhez TA, Vescovi P, Pizzi S, Meleti M (2024) Salivary diagnosis of dental caries: a systematic review. Curr Issues Mol Biol 46:4234\u20134250. https:\/\/doi.org\/10.3390\/cimb46050258","journal-title":"Curr Issues Mol Biol"},{"key":"4_CR8","doi-asserted-by":"publisher","DOI":"10.3389\/fchem.2025.1627793","volume":"13","author":"S Arunachalam","year":"2025","unstructured":"Arunachalam S, Balamurali MM, Gnanasekaran R (2025) Computational insights into novel inhibitors: virtual screening of small molecules against human carbonic anhydrase II. Front Chem 13:1627793. https:\/\/doi.org\/10.3389\/fchem.2025.1627793","journal-title":"Front Chem"},{"key":"4_CR9","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1113\/JP283579","volume":"601","author":"A Aspatwar","year":"2023","unstructured":"Aspatwar A, Supuran CT, Waheed A, Sly WS, Parkkila S (2023) Mitochondrial carbonic anhydrase VA and VB: properties and roles in health and disease. J Physiol 601:257\u2013274. https:\/\/doi.org\/10.1113\/JP283579","journal-title":"J Physiol"},{"key":"4_CR10","doi-asserted-by":"publisher","first-page":"3783","DOI":"10.1007\/s00018-019-03170-w","volume":"76","author":"RL Bernardino","year":"2019","unstructured":"Bernardino RL, Carrageta DF, Sousa M, Alves MG, Oliveira PF (2019) pH and male fertility: making sense on pH homeodynamics throughout the male reproductive tract. Cell Mol Life Sci 76:3783\u20133800. https:\/\/doi.org\/10.1007\/s00018-019-03170-w","journal-title":"Cell Mol Life Sci"},{"key":"4_CR11","doi-asserted-by":"publisher","first-page":"19460","DOI":"10.1021\/acs.jmedchem.4c01795","volume":"67","author":"E Berrino","year":"2024","unstructured":"Berrino E, Michelet B, Vitse K, Nocentini A, Bartolucci G, Martin-Mingot A, Gratteri P, Carta F, Supuran CT, Thibaudeau S (2024) Superacid-synthesized fluorinated diamines act as selective hCA IV inhibitors. J Med Chem 67:19460\u201319474. https:\/\/doi.org\/10.1021\/acs.jmedchem.4c01795","journal-title":"J Med Chem"},{"key":"4_CR12","doi-asserted-by":"publisher","first-page":"7422","DOI":"10.1021\/acs.jmedchem.0c00733","volume":"63","author":"A Bonardi","year":"2020","unstructured":"Bonardi A, Nocentini A, Bua S, Combs J, Lomelino C, Andring J, Lucarini L, Sgambellone S, Masini E, McKenna R, Gratteri P, Supuran CT (2020) Sulfonamide inhibitors of human carbonic anhydrases designed through a three-tails approach: improving ligand\/isoform matching and selectivity of action. J Med Chem 63:7422\u20137444. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c00733","journal-title":"J Med Chem"},{"key":"4_CR13","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1080\/14756366.2022.2053526","volume":"37","author":"A Bonardi","year":"2022","unstructured":"Bonardi A, Bua S, Combs J, Lomelino C, Andring J, Osman SM, Toti A, Di Cesare Mannelli L, Gratteri P, Ghelardini C, McKenna R, Nocentini A, Supuran CT (2022) The three-tails approach as a new strategy to improve selectivity of action of sulphonamide inhibitors against tumour-associated carbonic anhydrase IX and XII. J Enzyme Inhib Med Chem 37:930\u2013939. https:\/\/doi.org\/10.1080\/14756366.2022.2053526","journal-title":"J Enzyme Inhib Med Chem"},{"key":"4_CR14","doi-asserted-by":"publisher","first-page":"13143","DOI":"10.1021\/acs.jmedchem.2c00982","volume":"65","author":"A Bonardi","year":"2022","unstructured":"Bonardi A, Micheli L, Di Cesare Mannelli L, Ghelardini C, Gratteri P, Nocentini A, Supuran CT (2022) Development of hydrogen sulfide-releasing carbonic anhydrase IX- and XII-selective inhibitors with enhanced antihyperalgesic action in a rat model of arthritis. J Med Chem 65:13143\u201313157. https:\/\/doi.org\/10.1021\/acs.jmedchem.2c00982","journal-title":"J Med Chem"},{"key":"4_CR15","doi-asserted-by":"publisher","first-page":"9613","DOI":"10.1021\/acs.jmedchem.4c00740","volume":"67","author":"A Bonardi","year":"2024","unstructured":"Bonardi A, Nocentini A, Giovannuzzi S, Paoletti N, Ammara A, Bua S, Abutaleb NS, Abdelsattar AS, Capasso C, Gratteri P, Flaherty DP, Seleem MN, Supuran CT (2024) Development of penicillin-based carbonic anhydrase inhibitors targeting multidrug-resistant Neisseria gonorrhoeae. J Med Chem 67:9613\u20139627. https:\/\/doi.org\/10.1021\/acs.jmedchem.4c00740","journal-title":"J Med Chem"},{"key":"4_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms251810006","volume":"25","author":"A Bonardi","year":"2024","unstructured":"Bonardi A, Nocentini A, de Luca V, Capasso C, Elkaeed EB, Eldehna WM, Supuran CT (2024) Hydrogen sulfide-releasing carbonic anhydrase inhibitors effectively suppress cancer cell growth. Int J Mol Sci 25:10006. https:\/\/doi.org\/10.3390\/ijms251810006","journal-title":"Int J Mol Sci"},{"key":"4_CR17","doi-asserted-by":"publisher","first-page":"10949","DOI":"10.1073\/pnas.92.24.10949","volume":"92","author":"PA Boriack-Sjodin","year":"1995","unstructured":"Boriack-Sjodin PA, Heck RW, Laipis PJ, Silverman DN, Christianson DW (1995) Structure determination of murine mitochondrial carbonic anhydrase V at 2.45-\u00c5 resolution: implications for catalytic proton transfer and inhibitor design. Proc Natl Acad Sci USA 92:10949\u201310953. https:\/\/doi.org\/10.1073\/pnas.92.24.10949","journal-title":"Proc Natl Acad Sci USA"},{"key":"4_CR18","unstructured":"British Columbia Cancer Agency (2018) A study of SLC-0111 and gemcitabine for metastatic pancreatic ductal cancer in subjects positive for CAIX (SLC-0111-17-01). ClinicalTrials.gov Identifier: NCT03450018"},{"key":"4_CR19","doi-asserted-by":"publisher","first-page":"D564","DOI":"10.1093\/nar\/gkae1091","volume":"53","author":"SK Burley","year":"2025","unstructured":"Burley SK, Bhatt R, Bhikadiya C, Bi C, Biester A, Biswas P, Bittrich S, Blaumann S, Brown R, Chao H, Chithari VR, Craig PA, Crichlow GV, Duarte JM, Dutta S, Feng Z, Flatt JW, Ghosh S, Goodsell DS, Green RK, Guranovic V, Henry J, Hudson BP, Joy M, Kaelber JT, Khokhriakov I, Lai JS, Lawson CL, Liang Y, Myers-Turnbull D, Peisach E, Persikova I, Piehl DW, Pingale A, Rose Y, Sagendorf J, Sali A, Segura J, Sekharan M, Shao C, Smith J, Trumbull M, Vallat B, Voigt M, Webb B, Whetstone S, Wu-Wu A, Xing T, Young JY, Zalevsky A, Zardecki C (2025) Updated resources for exploring experimentally determined PDB structures and computed structure models at the RCSB Protein Data Bank. Nucleic Acids Res 53:D564\u2013D574. https:\/\/doi.org\/10.1093\/nar\/gkae1091","journal-title":"Nucleic Acids Res"},{"key":"4_CR20","doi-asserted-by":"publisher","first-page":"5048","DOI":"10.1002\/alz.13063","volume":"19","author":"E Canepa","year":"2023","unstructured":"Canepa E, Parodi-Rullan R, Vazquez-Torres R, Gamallo-Lana B, Guzman-Hernandez R, Lemon NL, Angiulli F, Debure L, Ilies MA, \u00d8stergaard L, Wisniewski T, Guti\u00e9rrez-Jim\u00e9nez E, Mar AC, Fossati S (2023) FDA-approved carbonic anhydrase inhibitors reduce amyloid \u03b2 pathology and improve cognition by ameliorating cerebrovascular health and glial fitness. Alzheimers Dement 19:5048\u20135073. https:\/\/doi.org\/10.1002\/alz.13063","journal-title":"Alzheimers Dement"},{"key":"4_CR21","doi-asserted-by":"publisher","first-page":"5465","DOI":"10.1080\/07391102.2022.2087736","volume":"41","author":"V Chahal","year":"2023","unstructured":"Chahal V, Kakkar R (2023) A combination strategy of structure-based virtual screening, MM-GBSA, cross docking, molecular dynamics and metadynamics simulations used to investigate natural compounds as potent and specific inhibitors of tumor-linked human carbonic anhydrase IX. J Biomol Struct Dyn 41:5465\u20135480. https:\/\/doi.org\/10.1080\/07391102.2022.2087736","journal-title":"J Biomol Struct Dyn"},{"key":"4_CR22","doi-asserted-by":"publisher","first-page":"8767","DOI":"10.1039\/d3cp05846h","volume":"26","author":"T Cheng","year":"2024","unstructured":"Cheng T, Wang N, Wen R, Wang S, Zhang H, Cheng M (2024) Discovery of non-sulfonamide carbonic anhydrase IX inhibitors through structure-based virtual screening. Phys Chem Chem Phys 26:8767\u20138774. https:\/\/doi.org\/10.1039\/d3cp05846h","journal-title":"Phys Chem Chem Phys"},{"key":"4_CR23","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2019.111565","volume":"181","author":"G Costa","year":"2019","unstructured":"Costa G, Carta F, Ambrosio FA, Artese A, Ortuso F, Moraca F, Rocca R, Romeo I, Lupia A, Maruca A, Bagetta D, Catalano R, Vullo D, Alcaro S, Supuran CT (2019) A computer-assisted discovery of novel potential anti-obesity compounds as selective carbonic anhydrase VA inhibitors. Eur J Med Chem 181:111565. https:\/\/doi.org\/10.1016\/j.ejmech.2019.111565","journal-title":"Eur J Med Chem"},{"key":"4_CR24","doi-asserted-by":"publisher","DOI":"10.1002\/ardp.202200383","volume":"356","author":"L De Luca","year":"2023","unstructured":"De Luca L, Angeli A, Ricci F, Supuran CT, Gitto R (2023) Structure-guided identification of a selective sulfonamide-based inhibitor targeting the human carbonic anhydrase VA isoform. Arch Pharm (Weinheim) 356:e2200383. https:\/\/doi.org\/10.1002\/ardp.202200383","journal-title":"Arch Pharm (Weinheim)"},{"key":"4_CR25","doi-asserted-by":"publisher","first-page":"679","DOI":"10.2174\/138161208783877938","volume":"14","author":"JM Dogn\u00e9","year":"2008","unstructured":"Dogn\u00e9 JM, Thiry A, Supuran CT (2008) Carbonic anhydrase inhibition: insight into non-COX-2 pharmacological effect of some coxibs. Curr Pharm Des 14:679\u2013684. https:\/\/doi.org\/10.2174\/138161208783877938","journal-title":"Curr Pharm Des"},{"key":"4_CR26","doi-asserted-by":"publisher","first-page":"10046","DOI":"10.1021\/bi050610h","volume":"44","author":"DM Duda","year":"2005","unstructured":"Duda DM, Tu C, Fisher SZ, An H, Yoshioka C, Govindasamy L, Laipis PJ, Agbandje-McKenna M, Silverman DN, McKenna R (2005) Human carbonic anhydrase III: structural and kinetic study of catalysis and proton transfer. Biochemistry 44:10046\u201310053. https:\/\/doi.org\/10.1021\/bi050610h","journal-title":"Biochemistry"},{"key":"4_CR27","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1007\/s40618-023-02008-4","volume":"46","author":"L Fei","year":"2023","unstructured":"Fei L, Cantini G, Nocentini A, Nardini P, Catarinicchia S, Canu L, Ercolino T, Quartararo G, Nesi G, Gacci M, Maggi M, Hantel C, Mannelli M, Supuran CT, Luconi M (2023) Carbonic anhydrases III and IX are new players in the crosstalk between adrenocortical carcinoma and its altered adipose microenvironment. J Endocrinol Investig 46:1449\u20131458. https:\/\/doi.org\/10.1007\/s40618-023-02008-4","journal-title":"J Endocrinol Investig"},{"key":"4_CR28","doi-asserted-by":"publisher","first-page":"4080","DOI":"10.1021\/acsomega.0c06153","volume":"6","author":"S Galati","year":"2021","unstructured":"Galati S, Yonchev D, Rodr\u00edguez-P\u00e9rez R, Vogt M, Tuccinardi T, Bajorath J (2021) Predicting isoform-selective carbonic anhydrase inhibitors via machine learning and rationalizing structural features important for selectivity. ACS Omega 6:4080\u20134089. https:\/\/doi.org\/10.1021\/acsomega.0c06153","journal-title":"ACS Omega"},{"key":"4_CR29","doi-asserted-by":"publisher","first-page":"4760","DOI":"10.1021\/acs.jcim.2c00910","volume":"62","author":"ME Gantner","year":"2022","unstructured":"Gantner ME, Prada Gori DN, Llanos MA, Talevi A, Angeli A, Vullo D, Supuran CT, Gavernet L (2022) Identification of new carbonic anhydrase VII inhibitors by structure-based virtual screening. J Chem Inf Model 62:4760\u20134770. https:\/\/doi.org\/10.1021\/acs.jcim.2c00910","journal-title":"J Chem Inf Model"},{"key":"4_CR30","doi-asserted-by":"publisher","DOI":"10.1080\/14756366.2023.2202360","volume":"38","author":"S Giovannuzzi","year":"2023","unstructured":"Giovannuzzi S, Bonardi A, Gratteri P, Nocentini A, Supuran CT (2023) Discovery of the first-in-class potent and isoform-selective human carbonic anhydrase III inhibitors. J Enzyme Inhib Med Chem 38:2202360. https:\/\/doi.org\/10.1080\/14756366.2023.2202360","journal-title":"J Enzyme Inhib Med Chem"},{"key":"4_CR31","doi-asserted-by":"publisher","first-page":"4170","DOI":"10.1021\/acs.jmedchem.4c00045","volume":"67","author":"S Giovannuzzi","year":"2024","unstructured":"Giovannuzzi S, Chavarria D, Provensi G, Leri M, Bucciantini M, Carradori S, Bonardi A, Gratteri P, Borges F, Nocentini A, Supuran CT (2024) Dual inhibitors of brain carbonic anhydrases and monoamine oxidase-B efficiently protect against amyloid-\u03b2-induced neuronal toxicity, oxidative stress, and mitochondrial dysfunction. J Med Chem 67:4170\u20134193. https:\/\/doi.org\/10.1021\/acs.jmedchem.4c00045","journal-title":"J Med Chem"},{"key":"4_CR32","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1080\/14756366.2020.1828401","volume":"35","author":"P Guglielmi","year":"2020","unstructured":"Guglielmi P, Rotondi G, Secci D, Angeli A, Chimenti P, Nocentini A, Bonardi A, Gratteri P, Carradori S, Supuran CT (2020) Novel insights on saccharin- and acesulfame-based carbonic anhydrase inhibitors: design, synthesis, modelling investigations and biological activity evaluation. J Enzyme Inhib Med Chem 35:1891\u20131905. https:\/\/doi.org\/10.1080\/14756366.2020.1828401","journal-title":"J Enzyme Inhib Med Chem"},{"key":"4_CR33","doi-asserted-by":"publisher","DOI":"10.1016\/j.sbi.2025.103193","volume":"96","author":"J Jiang","year":"2025","unstructured":"Jiang J, Li D, Wang G, Wei GW (2025) Recent advances in machine learning predictions of protein\u2013ligand binding affinities. Curr Opin Struct Biol 96:103193. https:\/\/doi.org\/10.1016\/j.sbi.2025.103193","journal-title":"Curr Opin Struct Biol"},{"key":"4_CR34","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1038\/s41586-021-03819-2","volume":"596","author":"J Jumper","year":"2021","unstructured":"Jumper J, Evans R, Pritzel A, Green T, Figurnov M, Ronneberger O, Tunyasuvunakool K, Bates R, \u017d\u00eddek A, Potapenko A, Bridgland A, Meyer C, Kohl SAA, Ballard AJ, Cowie A, Romera-Paredes B, Nikolov S, Jain R, Adler J, Back T, Petersen S, Reiman D, Clancy E, Zielinski M, Steinegger M, Pacholska M, Berghammer T, Bodenstein S, Silver D, Vinyals O, Senior AW, Kavukcuoglu K, Kohli P, Hassabis D (2021) Highly accurate protein structure prediction with AlphaFold. Nature 596:583\u2013589. https:\/\/doi.org\/10.1038\/s41586-021-03819-2","journal-title":"Nature"},{"key":"4_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2019.111642","volume":"182","author":"S Kalinin","year":"2019","unstructured":"Kalinin S, Nocentini A, Kovalenko A, Sharoyko V, Bonardi A, Angeli A, Gratteri P, Tennikova TB, Supuran CT, Krasavin M (2019) From random to rational: a discovery approach to selective subnanomolar inhibitors of human carbonic anhydrase IV based on the Castagnoli\u2013Cushman multicomponent reaction. Eur J Med Chem 182:111642. https:\/\/doi.org\/10.1016\/j.ejmech.2019.111642","journal-title":"Eur J Med Chem"},{"key":"4_CR36","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1002\/jcc.27335","volume":"45","author":"KK K\u0131rbo\u011fa","year":"2024","unstructured":"K\u0131rbo\u011fa KK, I\u015f\u0131k M (2024) Explainable artificial intelligence in the design of selective carbonic anhydrase I\u2013II inhibitors via molecular fingerprinting. J Comput Chem 45:1530\u20131539. https:\/\/doi.org\/10.1002\/jcc.27335","journal-title":"J Comput Chem"},{"key":"4_CR37","doi-asserted-by":"publisher","first-page":"5100","DOI":"10.1021\/acs.jcim.1c01319","volume":"62","author":"SR Krishnan","year":"2022","unstructured":"Krishnan SR, Bung N, Vangala SR, Srinivasan R, Bulusu G, Roy A (2022) De novo structure-based drug design using deep learning. J Chem Inf Model 62:5100\u20135109. https:\/\/doi.org\/10.1021\/acs.jcim.1c01319","journal-title":"J Chem Inf Model"},{"key":"4_CR38","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2022.105920","volume":"126","author":"A Kumar","year":"2022","unstructured":"Kumar A, Siwach K, Supuran CT, Sharma PK (2022) A decade of tail-approach-based design of selective as well as potent tumor-associated carbonic anhydrase inhibitors. Bioorg Chem 126:105920. https:\/\/doi.org\/10.1016\/j.bioorg.2022.105920","journal-title":"Bioorg Chem"},{"key":"4_CR39","doi-asserted-by":"publisher","first-page":"7830","DOI":"10.1109\/JBHI.2024.3504851","volume":"29","author":"C Lei","year":"2025","unstructured":"Lei C, Wang W, Fan W, Lu Z, Tang J, Li M (2025) TransScore: a graph model for pose scoring and affinity prediction based on transformer convolution network. IEEE J Biomed Health Inform 29:7830\u20137838. https:\/\/doi.org\/10.1109\/JBHI.2024.3504851","journal-title":"IEEE J Biomed Health Inform"},{"key":"4_CR40","doi-asserted-by":"publisher","DOI":"10.3389\/fnagi.2021.772278","volume":"13","author":"N Lemon","year":"2021","unstructured":"Lemon N, Canepa E, Ilies MA, Fossati S (2021) Carbonic anhydrases as potential targets against neurovascular unit dysfunction in Alzheimer\u2019s disease and stroke. Front Aging Neurosci 13:772278. https:\/\/doi.org\/10.3389\/fnagi.2021.772278","journal-title":"Front Aging Neurosci"},{"key":"4_CR41","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1080\/14756366.2016.1217857","volume":"31","author":"F Margheri","year":"2016","unstructured":"Margheri F, Ceruso M, Carta F, Laurenzana A, Maggi L, Lazzeri S, Simonini G, Annunziato F, Del Rosso M, Supuran CT, Cimaz R (2016) Overexpression of the transmembrane carbonic anhydrase isoforms IX and XII in the inflamed synovium. J Enzyme Inhib Med Chem 31:60\u201363. https:\/\/doi.org\/10.1080\/14756366.2016.1217857","journal-title":"J Enzyme Inhib Med Chem"},{"key":"4_CR42","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1097\/COC.0000000000000691","volume":"43","author":"PC McDonald","year":"2020","unstructured":"McDonald PC, Chia S, Bedard PL, Chu Q, Lyle M, Tang L, Singh M, Zhang Z, Supuran CT, Renouf DJ, Dedhar S (2020) A phase 1 study of SLC-0111, a novel inhibitor of carbonic anhydrase IX, in patients with advanced solid tumors. Am J Clin Oncol 43:484\u2013490. https:\/\/doi.org\/10.1097\/COC.0000000000000691","journal-title":"Am J Clin Oncol"},{"key":"4_CR43","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1080\/13543776.2018.1508453","volume":"28","author":"A Nocentini","year":"2018","unstructured":"Nocentini A, Supuran CT (2018) Carbonic anhydrase inhibitors as antitumor\/antimetastatic agents: a patent review (2008\u20132018). Expert Opin Ther Pat 28:729\u2013740. https:\/\/doi.org\/10.1080\/13543776.2018.1508453","journal-title":"Expert Opin Ther Pat"},{"key":"4_CR44","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1080\/17460441.2019.1651289","volume":"14","author":"A Nocentini","year":"2019","unstructured":"Nocentini A, Supuran CT (2019) Advances in the structural annotation of human carbonic anhydrases and impact on future drug discovery. Expert Opin Drug Discov 14:1175\u20131197. https:\/\/doi.org\/10.1080\/17460441.2019.1651289","journal-title":"Expert Opin Drug Discov"},{"key":"4_CR45","doi-asserted-by":"publisher","first-page":"2515","DOI":"10.1016\/j.bmcl.2011.02.059","volume":"21","author":"N Pala","year":"2011","unstructured":"Pala N, Dallocchio R, Dess\u00ec A, Brancale A, Carta F, Ihm S, Maresca A, Sechi M, Supuran CT (2011) Virtual screening-driven identification of human carbonic anhydrase inhibitors incorporating an original, new pharmacophore. Bioorg Med Chem Lett 21:2515\u20132520. https:\/\/doi.org\/10.1016\/j.bmcl.2011.02.059","journal-title":"Bioorg Med Chem Lett"},{"key":"4_CR46","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejmech.2025.118043","volume":"298","author":"N Pala","year":"2025","unstructured":"Pala N, Ladu F, Szlasa W, Cadoni R, Lomelino C, Mahon BP, Gulkis M, McKenna R, Dess\u00ec A, Dallocchio R, Demelas A, Carcelli M, Rogolino D, Crosio C, Iaccarino C, Kulbacka J, Vullo D, Carta F, Supuran CT, Sechi M (2025) Design, anticancer activity, and mechanistic evaluation of a novel class of selective human carbonic anhydrase IX inhibitors featuring a trifluorodihydroxypropanone pharmacophore. Eur J Med Chem 298:118043. https:\/\/doi.org\/10.1016\/j.ejmech.2025.118043","journal-title":"Eur J Med Chem"},{"key":"4_CR47","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s11671-024-04154-x","volume":"19","author":"SR Pardeshi","year":"2024","unstructured":"Pardeshi SR, Gholap AD, Hatvate NT, Gharat KD, Naik JB, Omri A (2024) Advances in dorzolamide hydrochloride delivery: harnessing nanotechnology for enhanced ocular drug delivery in glaucoma management. Discov Nano 19:199. https:\/\/doi.org\/10.1186\/s11671-024-04154-x","journal-title":"Discov Nano"},{"key":"4_CR48","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.3390\/ph18071007","volume":"18","author":"L Piazza","year":"2025","unstructured":"Piazza L, Di Stefano M, Poles C, Bononi G, Poli G, Renzi G, Galati S, Giordano A, Macchia M, Carta F, Supuran CT, Tuccinardi T (2025) A machine learning platform for isoform-specific identification and profiling of human carbonic anhydrase inhibitors. Pharmaceuticals (Basel) 18:1007. https:\/\/doi.org\/10.3390\/ph18071007","journal-title":"Pharmaceuticals (Basel)"},{"key":"4_CR49","doi-asserted-by":"publisher","first-page":"485","DOI":"10.1016\/j.bbrc.2012.02.038","volume":"419","author":"ES Pilka","year":"2012","unstructured":"Pilka ES, Kochan G, Oppermann U, Yue WW (2012) Crystal structure of the secretory isozyme of mammalian carbonic anhydrases CA VI: implications for biological assembly and inhibitor development. Biochem Biophys Res Commun 419:485\u2013489. https:\/\/doi.org\/10.1016\/j.bbrc.2012.02.038","journal-title":"Biochem Biophys Res Commun"},{"key":"4_CR50","doi-asserted-by":"publisher","first-page":"7950","DOI":"10.3390\/ijms23147950","volume":"23","author":"V Pontecorvi","year":"2022","unstructured":"Pontecorvi V, Mori M, Picarazzi F, Zara S, Carradori S, Cataldi A, Angeli A, Berrino E, Chimenti P, Ciogli A, Secci D, Guglielmi P, Supuran CT (2022) Novel insights on human carbonic anhydrase inhibitors based on coumalic acid: design, synthesis, molecular modeling investigation, and biological studies. Int J Mol Sci 23:7950. https:\/\/doi.org\/10.3390\/ijms23147950","journal-title":"Int J Mol Sci"},{"key":"4_CR51","doi-asserted-by":"publisher","first-page":"3603","DOI":"10.1039\/d5md00208g","volume":"16","author":"V Pontecorvi","year":"2025","unstructured":"Pontecorvi V, Angeli A, Cutarella L, Mori M, Secci D, Coluccia M, Carradori S, Troiani A, Pepi F, Salvitti C, Di Noi A, Spano M, Arrighi F, De Falco E, Bordin A, Berrino E, Granese A, Chimenti P, Guglielmi P, Supuran CT (2025) Design, synthesis, molecular modelling investigation and biological studies of novel human carbonic anhydrase inhibitors based on coumalic acid. RSC Med Chem 16:3603\u20133621. https:\/\/doi.org\/10.1039\/d5md00208g","journal-title":"RSC Med Chem"},{"key":"4_CR52","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1080\/14756366.2020.1752201","volume":"35","author":"A Pustenko","year":"2020","unstructured":"Pustenko A, Nocentini A, Gratteri P, Bonardi A, Vozny I, \u017dalubovskis R, Supuran CT (2020) The antibiotic furagin and its derivatives are isoform-selective human carbonic anhydrase inhibitors. J Enzyme Inhib Med Chem 35:1011\u20131020. https:\/\/doi.org\/10.1080\/14756366.2020.1752201","journal-title":"J Enzyme Inhib Med Chem"},{"key":"4_CR53","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/bs.apha.2025.02.004","volume":"103","author":"M Saini","year":"2025","unstructured":"Saini M, Mehra N, Kumar G, Paul R, Kov\u00e1cs B (2025) Molecular and structure-based drug design: from theory to practice. Adv Pharmacol 103:121\u2013138. https:\/\/doi.org\/10.1016\/bs.apha.2025.02.004","journal-title":"Adv Pharmacol"},{"key":"4_CR54","doi-asserted-by":"publisher","DOI":"10.1016\/j.bioorg.2025.108224","volume":"156","author":"P Singh","year":"2025","unstructured":"Singh P, Arifuddin M, Supuran CT, Nerella SG (2025) Carbonic anhydrase inhibitors: structural insights and therapeutic potential. Bioorg Chem 156:108224. https:\/\/doi.org\/10.1016\/j.bioorg.2025.108224","journal-title":"Bioorg Chem"},{"key":"4_CR55","doi-asserted-by":"publisher","first-page":"5528","DOI":"10.1021\/ja068359w","volume":"129","author":"DK Srivastava","year":"2007","unstructured":"Srivastava DK, Jude KM, Banerjee AL, Haldar M, Manokaran S, Kooren J, Mallik S, Christianson DW (2007) Structural analysis of charge discrimination in the binding of inhibitors to human carbonic anhydrases I and II. J Am Chem Soc 129:5528\u20135537. https:\/\/doi.org\/10.1021\/ja068359w","journal-title":"J Am Chem Soc"},{"key":"4_CR56","doi-asserted-by":"publisher","first-page":"13589","DOI":"10.1073\/pnas.93.24.13589","volume":"93","author":"T Stams","year":"1996","unstructured":"Stams T, Nair SK, Okuyama T, Waheed A, Sly WS, Christianson DW (1996) Crystal structure of the secretory form of membrane-associated human carbonic anhydrase IV at 2.8-\u00c5 resolution. Proc Natl Acad Sci USA 93:13589\u201313594. https:\/\/doi.org\/10.1073\/pnas.93.24.13589","journal-title":"Proc Natl Acad Sci USA"},{"key":"4_CR57","doi-asserted-by":"publisher","unstructured":"Sun Y, Chen L, Jing Z, Li YY, Kim D, Gao JY, Noroozi R, Yi GY, Tetsassi Feugmo CG, Klinkova A, Sask K, Kristiadi A, Wang B, Gillies ER, Lu KP, Shi HH, Hu P (2025) Generative AI for the design of molecules: advances and challenges. J Chem Inf Model (in press). https:\/\/doi.org\/10.1021\/acs.jcim.5c02234","DOI":"10.1021\/acs.jcim.5c02234"},{"key":"4_CR58","doi-asserted-by":"publisher","first-page":"168","DOI":"10.1038\/nrd2467","volume":"7","author":"CT Supuran","year":"2008","unstructured":"Supuran CT (2008) Carbonic anhydrases: novel therapeutic applications for inhibitors and activators. Nat Rev Drug Discov 7:168\u2013181. https:\/\/doi.org\/10.1038\/nrd2467","journal-title":"Nat Rev Drug Discov"},{"key":"4_CR59","doi-asserted-by":"publisher","first-page":"961","DOI":"10.1080\/14737175.2016.1193009","volume":"16","author":"CT Supuran","year":"2016","unstructured":"Supuran CT (2016) Carbonic anhydrase inhibition and the management of neuropathic pain. Expert Rev Neurother 16:961\u2013968. https:\/\/doi.org\/10.1080\/14737175.2016.1193009","journal-title":"Expert Rev Neurother"},{"issue":"10","key":"4_CR60","doi-asserted-by":"publisher","first-page":"1233","DOI":"10.1042\/CS20210040","volume":"135","author":"CT Supuran","year":"2021","unstructured":"Supuran CT (2021) Emerging role of carbonic anhydrase inhibitors. Clin Sci (Lond) 135(10):1233\u20131249. https:\/\/doi.org\/10.1042\/CS20210040","journal-title":"Clin Sci (Lond)"},{"key":"4_CR61","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1080\/14756366.2022.2121393","volume":"37","author":"CT Supuran","year":"2022","unstructured":"Supuran CT (2022) Anti-obesity carbonic anhydrase inhibitors: challenges and opportunities. J Enzyme Inhib Med Chem 37:2478\u20132488. https:\/\/doi.org\/10.1080\/14756366.2022.2121393","journal-title":"J Enzyme Inhib Med Chem"},{"key":"4_CR62","doi-asserted-by":"publisher","DOI":"10.1124\/pharmrev.124.001125","volume":"77","author":"CT Supuran","year":"2025","unstructured":"Supuran CT (2025) Multi- and polypharmacology of carbonic anhydrase inhibitors. Pharmacol Rev 77:100004. https:\/\/doi.org\/10.1124\/pharmrev.124.001125","journal-title":"Pharmacol Rev"},{"key":"4_CR63","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1021\/acsmedchemlett.5c00443","volume":"16","author":"CT Supuran","year":"2025","unstructured":"Supuran CT (2025) Human carbonic anhydrase inhibitors. ACS Med Chem Lett 16:1889\u20131895. https:\/\/doi.org\/10.1021\/acsmedchemlett.5c00443","journal-title":"ACS Med Chem Lett"},{"key":"4_CR64","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1016\/bs.apha.2025.02.002","volume":"103","author":"S Sur","year":"2025","unstructured":"Sur S, Nimesh H (2025) Challenges and limitations of computer-aided drug design. Adv Pharmacol 103:415\u2013428. https:\/\/doi.org\/10.1016\/bs.apha.2025.02.002","journal-title":"Adv Pharmacol"},{"key":"4_CR65","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s13321-021-00499-y","volume":"13","author":"A Tinivella","year":"2021","unstructured":"Tinivella A, Pinzi L, Rastelli G (2021) Prediction of activity and selectivity profiles of human carbonic anhydrase inhibitors using machine learning classification models. J Cheminform 13:18. https:\/\/doi.org\/10.1186\/s13321-021-00499-y","journal-title":"J Cheminform"},{"key":"4_CR66","doi-asserted-by":"publisher","first-page":"16860","DOI":"10.1021\/jp8068877","volume":"112","author":"V Verdolino","year":"2008","unstructured":"Verdolino V, Cammi R, Munk BH, Schlegel HB (2008) Calculation of pKa values of nucleobases and the guanine oxidation products guanidinohydantoin and spiroiminodihydantoin using density functional theory and a polarizable continuum model. J Phys Chem B 112:16860\u201316873","journal-title":"J Phys Chem B"},{"key":"4_CR67","doi-asserted-by":"publisher","first-page":"3307","DOI":"10.1016\/j.bmc.2010.03.014","volume":"18","author":"W Vernier","year":"2010","unstructured":"Vernier W, Chong W, Rewolinski D, Greasley S, Pauly T, Shaw M, Dinh D, Ferre RA, Meador JW 3rd, Nukui S, Ornelas M, Paz RL, Reyner E (2010) Thioether benzenesulfonamide inhibitors of carbonic anhydrases II and IV: structure-based drug design, synthesis, and biological evaluation. Bioorg Med Chem 18:3307\u20133319. https:\/\/doi.org\/10.1016\/j.bmc.2010.03.014","journal-title":"Bioorg Med Chem"},{"key":"4_CR68","doi-asserted-by":"publisher","first-page":"W296","DOI":"10.1093\/nar\/gky427","volume":"46","author":"A Waterhouse","year":"2018","unstructured":"Waterhouse A, Bertoni M, Bienert S, Studer G, Tauriello G, Gumienny R, Heer FT, de Beer TAP, Rempfer C, Bordoli L, Lepore R, Schwede T (2018) SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res 46:W296\u2013W303. https:\/\/doi.org\/10.1093\/nar\/gky427","journal-title":"Nucleic Acids Res"},{"key":"4_CR69","doi-asserted-by":"publisher","first-page":"9545","DOI":"10.1073\/pnas.161301298","volume":"98","author":"DA Whittington","year":"2001","unstructured":"Whittington DA, Waheed A, Ulmasov B et al (2001) Crystal structure of the dimeric extracellular domain of human carbonic anhydrase XII, a bitopic membrane protein overexpressed in certain cancer tumor cells. Proc Natl Acad Sci USA 98:9545\u20139550. https:\/\/doi.org\/10.1073\/pnas.161301298","journal-title":"Proc Natl Acad Sci USA"},{"key":"4_CR70","doi-asserted-by":"publisher","first-page":"8924","DOI":"10.1021\/acs.jcim.5c00921","volume":"65","author":"S Xie","year":"2025","unstructured":"Xie S, Zhu H, Huang N (2025) AI-designed molecules in drug discovery, structural novelty evaluation, and implications. J Chem Inf Model 65:8924\u20138933. https:\/\/doi.org\/10.1021\/acs.jcim.5c00921","journal-title":"J Chem Inf Model"},{"key":"4_CR71","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1002\/2211-5463.13376","volume":"12","author":"H Yamamoto","year":"2022","unstructured":"Yamamoto H, Uramaru N, Kawashima A, Higuchi T (2022) Carbonic anhydrase 3 increases during liver adipogenesis even in pre-obesity, and its inhibitors reduce liver adipose accumulation. FEBS Open Bio 12:827\u2013834. https:\/\/doi.org\/10.1002\/2211-5463.13376","journal-title":"FEBS Open Bio"},{"key":"4_CR72","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1089\/ars.2024.0693","volume":"41","author":"Y Yu","year":"2024","unstructured":"Yu Y, Poulsen SA, Di Trapani G, Tonissen KF (2024) Exploring the redox and pH dimension of carbonic anhydrases in cancer: a focus on carbonic anhydrase 3. Antioxid Redox Signal 41:957\u2013975. https:\/\/doi.org\/10.1089\/ars.2024.0693","journal-title":"Antioxid Redox Signal"},{"key":"4_CR73","doi-asserted-by":"publisher","DOI":"10.1080\/0886022X.2025.2482125","volume":"47","author":"L Zhang","year":"2025","unstructured":"Zhang L, Feng E, Baima S, Laba C, Suolang L, Cang J, De Q (2025) High altitude renal syndrome: four elements or one source? Ren Fail 47:2482125. https:\/\/doi.org\/10.1080\/0886022X.2025.2482125","journal-title":"Ren Fail"}],"container-title":["Subcellular Biochemistry","Carbonic Anhydrase Inhibitors"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-032-23172-7_4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:46:15Z","timestamp":1777596375000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-032-23172-7_4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9783032231710","9783032231727"],"references-count":73,"URL":"https:\/\/doi.org\/10.1007\/978-3-032-23172-7_4","relation":{},"ISSN":["0306-0225","2542-8810"],"issn-type":[{"value":"0306-0225","type":"print"},{"value":"2542-8810","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"1 May 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}